Nanalysis Scientific Corp.
NSCIF
$0.11
$0.0112.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.77% | -13.01% | -17.46% | -10.84% | 21.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.77% | -13.01% | -17.46% | -10.84% | 21.87% |
| Cost of Revenue | -3.58% | -5.17% | -13.17% | -15.99% | -2.53% |
| Gross Profit | -30.56% | -32.87% | -28.48% | 8.43% | 136.61% |
| SG&A Expenses | -24.20% | -19.06% | -5.24% | -2.07% | -5.44% |
| Depreciation & Amortization | -52.66% | -25.14% | -10.03% | -25.56% | 5.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.95% | -10.62% | -9.91% | -14.89% | -1.25% |
| Operating Income | -6.48% | -14.34% | -71.93% | 41.35% | 116.57% |
| Income Before Tax | 90.00% | 10.46% | -6.57% | 53.14% | -537.03% |
| Income Tax Expenses | 40.41% | 427.27% | -459.09% | 525.42% | -102.67% |
| Earnings from Continuing Operations | 90.18% | 9.65% | -5.20% | 51.32% | -241.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.18% | 9.65% | -5.20% | 51.32% | -241.14% |
| EBIT | -6.48% | -14.34% | -71.93% | 41.35% | 116.57% |
| EBITDA | -21.04% | -785.09% | -1,814.27% | -51.42% | 133.32% |
| EPS Basic | 90.45% | 11.21% | -4.65% | 55.80% | -205.84% |
| Normalized Basic EPS | 21.62% | 9.68% | -19.18% | 54.72% | 62.63% |
| EPS Diluted | 84.71% | 35.37% | 0.68% | 55.80% | -205.84% |
| Normalized Diluted EPS | 21.62% | 9.68% | -19.18% | 54.72% | 62.63% |
| Average Basic Shares Outstanding | 3.61% | 1.52% | 0.45% | 9.65% | 11.47% |
| Average Diluted Shares Outstanding | 3.61% | 1.52% | 0.45% | 9.65% | 11.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |